Global Amniocentesis Needle Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Amniocentesis Needle Market size is expected to reach USD 456.55 Million in 2034 from USD 240.94 Million (2025) growing at a CAGR of 7.36% during 2026-2034.

The Global Amniocentesis Needle Market is witnessing steady growth due to the increasing prevalence of genetic disorders and rising maternal age worldwide. Amniocentesis procedures are widely performed for prenatal diagnosis of chromosomal abnormalities and inherited conditions. Growing awareness about early detection of fetal anomalies and advancements in prenatal screening technologies are significantly supporting market expansion across developed and developing regions.

Key growth drivers include rising demand for minimally invasive prenatal diagnostic procedures and improvements in needle design that enhance safety and precision. Increasing healthcare infrastructure development and the growing number of diagnostic laboratories are also contributing to demand. Additionally, supportive government initiatives promoting maternal health screening programs are positively influencing market growth.

Future prospects remain promising with continuous technological advancements aimed at reducing procedure-related risks. Integration of ultrasound-guided techniques and improved patient safety protocols will enhance adoption. Expanding access to prenatal care in emerging economies and increasing focus on early genetic testing are expected to drive sustained growth over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

100 to 150 mm
Smaller Than 100 mm
Larger Than 150 mm

By Procedure

Amniocentesis Procedures
Amnioreduction Procedures
Fetal Blood Transfusion
Amnioinfusion Procedure
Cordocentesis Procedure

By End-use

Hospitals
Diagnostics Centers
Clinics
Others

COMPANIES PROFILED

Smiths Medical, Biopsybell Srl, Integra LifeSciences, Laboratoire CCD, Cook Medical, RIMOS Srl, CooperSurgical, Medline, Rocket Medical, Becton Dickinson and Company
We can customise the report as per your requirements.

Product Code: VMR112113802

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type
4.2. 100 to 150 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Smaller Than 100 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Larger Than 150 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY PROCEDURE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Procedure
5.2. Amniocentesis Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Amnioreduction Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Fetal Blood Transfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Amnioinfusion Procedure Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Cordocentesis Procedure Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY END-USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End-use
6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Type
- 7.2.2 By Procedure
- 7.2.3 By End-use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Type
- 7.3.2 By Procedure
- 7.3.3 By End-use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Type
- 7.4.2 By Procedure
- 7.4.3 By End-use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Type
- 7.5.2 By Procedure
- 7.5.3 By End-use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Type
- 7.6.2 By Procedure
- 7.6.3 By End-use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AMNIOCENTESIS NEEDLE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Smiths Medical
- 9.2.2 Biopsybell Srl
- 9.2.3 Integra LifeSciences
- 9.2.4 Laboratoire CCD
- 9.2.5 Cook Medical
- 9.2.6 RI.MOS. Srl
- 9.2.7 CooperSurgical
- 9.2.8 Medline
- 9.2.9 Rocket Medical
- 9.2.10 Becton Dickinson And Company